A registry of Nation Japanese Radiation Oncology Study Group: Intensity-modulated radiation therapy for prostate cancer

A registry of Nation Japanese Radiation Oncology Study Group: Intensity-modulated radiation therapy for prostate cancer - JROSG-IMRT-PC01

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033172

Enrollment

1000

Registered

2018-07-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who 1)must be diagnosed as prostate cancer pathologically 2)have prostate adenocarinoma clinically staged with T1c-T4N0M0 3)must be at a score level of 70-100 of KPS; Karnofsky performance status

Exclusion criteria

Exclusion criteria: Patients who 1)have existence of any treatment, excluding androgen deprivation therapy for prostate cancer. 2)have active double cancer (synchronous double cancer and metachronous double cancer within 5 disease-free years), excluding carcinoma in situ (lesions equal to intraepithelial or intramucosal cancer) judged to have been cured with local treatment. 3)have history of pelvis irradiation

Design outcomes

Primary

Measure	Time frame
5-year rate of biochemical relapse free survival	—

Countries

Japan

Contacts

Public ContactHitoshi Ishikawa

University of Tsukuba, Faculty of Medicine Radiation Oncology

hishikawa@pmrc.tsukuba.ac.jp029-853-7100

Outcome results